Fortive (FTV) Q3 2026 earnings review
Fortive sales speed up, but debt costs slow net profit
Fortive, which makes industrial test tools and hospital equipment, sped up its sales while higher interest bills held back net profit. Sales from businesses owned a year ago rose 7%, above what the company's own plan pointed to. Chief executive Olumide Soroye raised the full-year per-share profit outlook to $3.10–$3.14, but by our math that leaves fourth-quarter profit per share up only 1%.
| Sales from businesses owned a year ago | +7.2% +6.7% last quarter |
|---|---|
| Profit per share, excluding one-offs | $0.77 +13.2% from a year ago |
| Net profit, excluding one-offs | $235.4M +3.1% from a year ago |
| Full-year profit per share outlook | Raised $0.12 middle of the range: $3.12 (+15%) |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because faster industrial sales and a higher outlook are offset by weak healthcare margins and rising debt costs. Excluding one-offs, net profit rose only 3% as interest expense jumped 53%, meaning share buybacks drove more than three-quarters of the per-share profit gain. One caution: beating the third-quarter profit plan says the target was cautious, not that fourth-quarter calendar headwinds have faded.
The question now is whether the flat fourth-quarter profit implied by the outlook is another cautious target or the moment when higher interest costs and a smaller buyback tailwind catch up with the business. Either Fortive beats easily again on industrial demand, or per-share profit growth drops toward the 3% net profit pace. Fourth-quarter results and the 2027 outlook will settle it.
🐂 Bull Case
Industrial Tools Carry the Top Line
Fortive makes industrial test tools, facility software and hospital equipment across two divisions. Chief executive Olumide Soroye said its "investments in innovation acceleration, commercial acceleration, and recurring customer value are contributing to faster revenue growth and strong financial performance." Sales from businesses owned a year ago grew 7.2%, speeding up for a fourth straight quarter.
Intelligent Operating Solutions (IOS), the industrial division that houses Fluke test instruments and maintenance software, did the heavy lifting. Its underlying sales rose 9.1%, up from 7.4% in the second quarter and 5.2% in the first. That beat the 4% company pace management pointed to three months ago.
What to watch: the volume share of underlying sales growth in the quarterly filing. A reading above 3% would show customer demand, rather than price increases, drove the speedup.
Lower Overhead Lifted Operating Profit
Fortive spent less of its revenue on selling and overhead this quarter, which lifted operating profit. Selling, general and administrative expenses (day-to-day sales and corporate overhead) dropped to 36.7% of sales from 41.6% a year ago. Even after stripping out $33 million of one-time separation stock pay from last year, overhead fell 1.7 percentage points by our math.
That cost discipline helped push the industrial division's Ebitda margin, excluding one-offs, up 1.2 percentage points to 35.8%. Company-wide Ebitda margin excluding one-offs rose half a percentage point to 30.6%.
What to watch: fourth-quarter Ebitda margin excluding one-offs. Keeping the full-year gain inside management's 0.5 to 1.0 percentage point target range requires holding these overhead savings through a shorter fourth quarter.
🐻 Bear Case
Share Buybacks Do Most of the Per-Share Work
"Q3 was another quarter of strong and accelerating performance for Fortive," Soroye said, pointing to 13.2% growth in profit per share excluding one-offs. The company also bought back about $300 million of its own stock in the quarter, stepping up from $200 million in the second quarter.
- Profit per share excluding one-offs: $0.77, up 13.2% from a year ago
- Net profit excluding one-offs: $235.4 million, up 3.1% from a year ago by our math
- Diluted share count: 303.9 million, down 8.8% from a year ago
- Nine-month share buybacks: $1.0 billion, against $748.2 million of free cash flow
This gap matters because share buybacks created more than three-quarters of the per-share profit growth. Actual net profit excluding one-offs barely grew, slowing from 15.5% growth in the second quarter to 3.1% in the third. Because nine-month buybacks exceeded free cash flow, the group funded part of those purchases with commercial paper debt.
What to watch: fourth-quarter diluted share count and buyback spending. As Fortive laps last year's large post-spin share repurchases, per-share profit growth will drop toward the 3% net profit pace unless net earnings speed up.
Debt Costs Erase Operating Gains, and Q4 Implies a Standstill
Soroye raised the full-year profit outlook to $3.10–$3.14 per share, "reflecting our strong year-to-date performance and our confidence in the trajectory of the business." Fortive also beat its third-quarter profit target by $0.08 per share. Under rule six, that beat shows the third-quarter plan was cautious, not that second-half headwinds have disappeared.
In fact, higher borrowing costs ate up most of this quarter's operating gains. Net interest expense jumped 52.8% from a year ago to $38.8 million, turning a 9.5% rise in Ebitda excluding one-offs into just 3.1% growth in net profit. By our math, the new full-year outlook leaves $0.89–$0.93 per share for the fourth quarter, or 1.1% growth at the middle of the range against $0.90 last year.
What to watch: fourth-quarter net interest expense against the $34.2 million implied by management's $140 million annual estimate. Another rise in interest costs would keep net profit flat even if factory sales hold up.
Healthcare Profit Fell as Sales Slowed
Advanced Healthcare Solutions (AHS), which sells hospital sterilization gear and medical software, lost momentum this quarter. After recovering in the first half of the year, its underlying revenue growth slowed to 3.1% from 5.3% in the second quarter. Segment Ebitda excluding one-offs fell 4.8% from a year ago to $87.9 million, and its margin dropped 2.3 percentage points to 25.8%.
Product mix also hurt the wider company's gross margin (profit left after the cost of making products) for a third straight quarter. Reported gross margin rose 1.0 percentage point to 64.2%, but that included $18.0 million of tariff refunds in cost of sales. Excluding those refunds, gross margin fell 0.7 percentage points to 62.5% by our math.
What to watch: healthcare underlying sales growth and segment margin in the fourth quarter. A second quarter of falling profit would show hospital equipment demand is stalling again.
Risks this quarter didn't answer
Four standing concerns and watch items cannot be read from the earnings release because the details live in the quarterly filing or conference call.
- European demand: flat to down for four quarters; the quarterly filing's geographic table will show whether third-quarter channel orders recovered.
- Fluke order book-to-bill: management's main short-cycle demand indicator is only given on the conference call.
- Software and recurring revenue: management has not given dollar figures for its six software brands or a year-ago comparison for its $824.8 million contract backlog.
- AI software defense: whether executives still need to defend the software portfolio against artificial intelligence tools on the call.
👓 Other Themes
Tariff Refunds Boosted Reported Profit
Following the Februari 2026 Supreme Court ruling that struck down certain emergency tariffs, U.S. Customs began paying refund claims. Fortive recorded $18.0 million of tariff refunds inside cost of sales this quarter, up from $4.5 million in the second quarter. The industrial group excludes these one-off gains from its adjusted profit figures, but future trade rules could still bring new replacement tariffs.
💲 Other KPIs
Free cash flow (operating cash left after factory equipment purchases) rose 6.7% from a year ago, slowing from 50.3% growth in the second quarter and 13.5% in the first. Over the past twelve months, the industrial group generated $1,062 million of free cash flow, up 15.2% from the prior year.
Net debt (total debt minus cash on hand) rose 10.8% from the end of 2025, reaching $3,137 million by our math. Fortive paid off $899.5 million of current debt since December, but it added $455.7 million in commercial paper borrowings to help fund $1.0 billion of nine-month share buybacks.
Inventories on the balance sheet rose 8.0% from the end of 2025 to $315.2 million, roughly matching the 7.8% rise in third-quarter sales. Meanwhile, customer bills waiting to be collected (accounts receivable) fell 2.1% over the same nine months to $669.5 million, helping bring in $11.2 million of operating cash.
🔮 Guidance
Raised. Management lifted the full-year range by $0.12 at the middle, calling for 15.1% growth for the year. By our math, subtracting $2.21 earned in the first nine months leaves $0.89–$0.93 for the fourth quarter, or 1.1% growth against $0.90 a year ago. It is the second raise this year (+$0.05 in Q2, +$0.12 in Q3) as four fewer fourth-quarter selling days weigh on the finish.
❓ Key Questions
Why did net profit growth slow to 3%?
Ebitda excluding one-offs grew 9.5%, but net profit excluding one-offs rose only 3.1% because net interest expense jumped 52.8% to $38.8 million. Will quarterly interest expense stay near $39 million into 2027?
What caused healthcare profit to drop 5%?
Advanced Healthcare Solutions underlying sales growth slowed from 5.3% to 3.1%, and its Ebitda margin fell 2.3 percentage points. Did hospital equipment orders stall again, or did one-time costs hit the division?
How much did volume drive the 7.2% sales growth?
The earnings release does not split underlying sales growth between price increases and shipment volume. How much of the third-quarter speedup came from selling more units?
What are the updated full-year sales targets?
The release updated only the full-year per-share profit outlook. After 7.2% underlying growth in the third quarter, what does management now expect for full-year underlying revenue growth and fourth-quarter sales?